PUBLICATION

A lmod1a mutation causes megacystis microcolon intestinal hypoperistalsis in a CRISPR/Cas9-modified zebrafish model

Authors
Kalim, A.S., Nagata, K., Toriigahara, Y., Shirai, T., Kirino, K., Xiu-Ying, Z., Kondo, T., Kawakubo, N., Miyata, J., Matsuura, T., Tajiri, T.
ID
ZDB-PUB-240815-10
Date
2024
Source
Pediatric surgery international   40: 225225 (Journal)
Registered Authors
Keywords
Animal model, CRISPR/Cas9, Lmod1a, MMIHS, Zebrafish
MeSH Terms
  • Abnormalities, Multiple/genetics
  • Animals
  • CRISPR-Cas Systems*
  • Colon*/abnormalities
  • Disease Models, Animal*
  • Intestinal Pseudo-Obstruction*/genetics
  • Muscle Proteins/genetics
  • Mutation
  • Urinary Bladder/abnormalities
  • Zebrafish*/genetics
  • Zebrafish Proteins/genetics
PubMed
39143337 Full text @ Pediatr. Surg. Int.
Abstract
Megacystis microcolon intestinal hypoperistalsis syndrome (MMIHS) is defined as a congenital visceral myopathy with genetic mutations. However, the etiology and pathophysiology are not fully understood. We aimed to generate a gene leiomodin-1a (lmod1a) modification technique to establish a zebrafish model of MMIHS.
We targeted lmod1a in zebrafish using CRISPR/Cas9. After confirming the genotype, we measured the expression levels of the target gene and protein associated with MMIHS. A gut transit assay and spatiotemporal mapping were conducted to analyze the intestinal function.
Genetic confirmation showed a 5-base-pair deletion in exon 1 of lmod1a, which caused a premature stop codon. We observed significant mRNA downregulation of lmod1a, myh11, myod1, and acta2 and the protein expression of Lmod1 and Acta2 in the mutant group. A functional analysis of the lmod1a mutant zebrafish showed that its intestinal peristalsis was fewer, slower, and shorter in comparison to the wild type.
This study showed that targeted deletion of lmod1a in zebrafish resulted in depletion of MMIHS-related genes and proteins, resulting in intestinal hypoperistalsis. This model may have the potential to be utilized in future therapeutic approaches, such as drug discovery screening and gene repair therapy for MMIHS.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping